AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03514641 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: Placebo (inactive) tablet to match the active drug
Study NCT04327713 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: fish oil supplement
Description: daily fish oil supplement vs. placebo
Study NCT03069508 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clemizole Hydrochloride
Description: Clemizole Hydrochloride will be administered orally for up to 24 weeks
Study NCT02707679 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Kinesiotaping
Description: Kinesiotaping was applied on patient with patellofemoral pain syndrome. To maintain proprioceptive stimulation in the quadriceps (from origo towards insertio) and to alleviate the tension of hamstring muscle, a 'Y''-shaped kinesiotape was applied by using the muscle technique.
Study NCT02707679 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Exercise
Description: All the patients were provided with several exercises within the scope of the home exercise program, such as hamstring muscle stretching, quadriceps isometric exercises, 4-way-strengthening with exercise elastic bands for the muscles of the hip, knee locking on foot and mini-squatting exercises. They were asked to do these exercises in 3 sets a day along with 10 repetitions for a period of 6 weeks.
Study NCT00605696 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin
Description: Participants will receive intravenous insulin to target tight glycemic control (80 to 110 mg/dL) for up to 48 hours after ICU admission.
Study NCT02570113 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Peregrine System Infusion Catheter
Description: The Peregrine Catheter is inserted bilaterally into the renal arteries and a specified amount of a neurolytic agent is inserted into the vessel walls.
Study NCT01631175 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: psychosocial treatment
Description: psychosocial treatment, verbal therapy, relaxation exercises
Study NCT03377764 — intervention group
Intervention type: PROCEDURE
Intervention: Landmark Technique Control group
Description: Spinal Anesthetic
Study NCT03377764 — intervention group
Intervention type: PROCEDURE
Intervention: Neuroaxial block using Ultrasound Guidance
Description: Ultrasound guided Spinal Anesthetic
Study NCT02731417 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: Acupuncture for women with post partum urinary retention
Study NCT02731417 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Foley catheter
Description: Foley catheter insertion for women with post partum urinary retention.
Study NCT00505375 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CTLA-4 Ig
Description: Intravenous infusion of 10 mg/kg of CTLA-4 Ig every other week for the first two doses and then every 28 days for a total of 27 doses
Study NCT00505375 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intravenous infusions of placebo every other week for the first two doses and then every 28 days for a total of 27 doses
Study NCT03907384 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mat Pilates training
Description: This group completed 12-weeks of training
Study NCT01295294 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: 500 mg 3 times daily per oral during bleeding/spotting episodes
Study NCT01295294 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Description: 500 mg 3 times daily per oral during bleeding/spotting episodes
Study NCT01295294 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 3 times daily per oral during bleeding/spotting episodes
Study NCT01295294 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirena (Levonorgestrel IUS, BAY86-5028)
Description: In vitro release rate 20 microgram/24 hours. Intrauterine system
Study NCT01295294 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Mirena (Levonorgestrel IUS, BAY86-5028)
Description: In vitro release rate 20 microgram/24 hours. Intrauterine system
Study NCT00587600 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Photodynamic therapy
Description: Photofrin 2mg/kg Photoradiation The light dose delivered will be a total of 200 joules per centimeter fiber which has previously been shown to ablate Barrett's mucosa.
Study NCT00587600 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: radiofrequency ablation of barrett's esophagus
Description: radiofrequency ablation
Study NCT02715934 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glucose to Goal
Description: The Glucose to Goal intervention applies elements of the Patient Centered Medical Home (i.e., practice design, decision support, population management, etc) to diabetes education services and operationalizes the current DSME objectives in the primary care setting.
Study NCT02715934 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual Care
Description: The control group will follow the traditional DMSE delivery model, which includes primary care providers referring patients to an outpatient, hospital-based diabetes educator for DSME, but in a passive manner (i.e., without proactive patient identification), which is the usual process for referrals.
Study NCT03230799 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: minimal invasive lens surgery
Description: We decreased the size of the capsulorhexis opening to 1.0-1.5 mm in diameter. Then we moved the location of the capsulorhexis to the peripheral area of the lens instead of the central area. A 0.9 mm phacoemulsification probe was used to remove the lens contents and/or cortical opacities.
Study NCT00605696 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin
Description: Participants will receive intravenous insulin to target tight glycemic control (80 to 110 mg/dL) for up to 48 hours after ICU admission.
Study NCT02016222 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: tears sampling
Study NCT03017105 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cross-education of strength-training
Description: Strength-training exercises using isometric contractions and resistance bands to be performed with the uninjured arm
Study NCT03017105 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual rehabilitation
Description: Exercises to improve range of movement, strength and movement control (as standard for non-operatively managed proximal humerus fractures)
Study NCT03017105 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual rehabilitation
Description: Exercises to improve range of movement, strength and movement control (as standard for non-operatively managed proximal humerus fractures)
Study NCT00598819 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CDI 1000 COM
Description: CDI 1000 COM sensors were attached to subject's forehead for a 12 hour period.
Study NCT04133025 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Vestibular Rehabilitation
Description: Vestibular Exercises and Software in vestibular rehabilitation
Study NCT01186250 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pioglitazone
Description: 15mg pioglitazone taken daily for one month, 30mg pioglitazone taken daily for another month, 45mg pioglitazone taken daily for remaining ten months
Study NCT01186250 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo taken daily for one year
Study NCT00368030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eszopiclone
Description: Eszopiclone 3 mg QD
Study NCT02994381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RPC1063
Study NCT04110860 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: voriconazole gel once daily
Description: voriconazole is incorporated into a nanoemulsion intermediate gel state then applied on the affected areas once daily
Study NCT04110860 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: voriconazole gel twice daily
Description: voriconazole is incorporated into a nanoemulsion intermediate gel state then applied on the affected areas twice daily
Study NCT04110860 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: the same procedure as before is used to prepare the nanoemulsion intermediate gel but the active ingredient, voriconazole, is not added then applied twice daily in the same manner
Study NCT04709718 — intervention group
Intervention type: PROCEDURE
Intervention: hepatectomy
Description: liver resection taking over the liver hemangioma
Study NCT00871091 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: orthodontic treatment with customized archwires
Description: customized arch wires depending on the amount of needed tooth movement
Study NCT00871091 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: orthodontic treatment with prefabricated archwires
Description: prefabricated archwires depending of the needed movement of the teeth
Study NCT00871091 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: orthodontic tx w/ conventional archwires+manual adjustments
Description: conventional archwires modified by manual adjustment, depending of needed correction
Study NCT00352313 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATN-161
Description: Given IV
Study NCT00352313 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin
Description: Given IV
Study NCT04359342 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: HIIT + protein
Description: 8-week supervised exercise program consisting of high-intensity interval training (HIIT).~HIIT: 10x1 min at 85-95% HRmax divided by low intensity recovery periods. Three exercise sessions per week. Participants receive 40 g of a commercially available protein supplement administered as a shake after every exercise session.
Study NCT04359342 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: HIIT + placebo
Description: 8-week supervised exercise program consisting of high-intensity interval training (HIIT).~HIIT: 10x1 min at 85-95% HRmax divided by low intensity recovery periods. Three exercise sessions per week. Participants receive 40 g of a commercially available iso-caloric placebo (Maltodextrin) administered as a shake after every exercise session.
Study NCT04359342 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: HIIT and resistance training + protein
Description: 8-week supervised exercise program consisting of high-intensity interval training (HIIT) and resistance training (RST).~HIIT: 5x1 min at 85-95% HRmax divided by low intensity recovery periods. RST: 3-set resistance training using weight machines to train all major muscle groups with an individual intensity corresponding to 70-80% of one repetition maximum. Two exercise sessions per week. Participants receive 40 g of a commercially available protein supplement administered as a shake after every exercise session.
Study NCT04359342 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: HIIT and resistance training + placebo
Description: 8-week supervised exercise program consisting of high-intensity interval training (HIIT) and resistance training (RST).~HIIT: 5x1 min at 85-95% HRmax divided by low intensity recovery periods. RST: 3-set resistance training using weight machines to train all major muscle groups with an individual intensity corresponding to 70-80% of one repetition maximum. Two exercise sessions per week. Participants receive 40 g of a commercially available iso-caloric placebo (Maltodextrin) administered as a shake after every exercise session.
Study NCT04565600 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoricoxib
Description: Etoricoxib 60 Mg Oral Tablet
Study NCT02661464 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV
Description: No vaccine will be administered in the current study. Safety data will be collected from participants who were previously exposed to Ad26.ZEBOV vaccine in Phase 1, 2, or 3 clinical studies up to 60 months and also safety data will be collected from live born children to female participants up to 60 months after birth.
Study NCT02661464 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MVA-BN-Filo
Description: No vaccine will be administered in the current study. Safety data will be collected from participants who were previously exposed to MVA-BN-Filo vaccine in Phase 1, 2, or 3 clinical studies up to 60 months and also safety data will be collected from live born children to female participants up to 60 months after birth.
Study NCT01367860 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open microdiscectomy
Description: The open microdiscectomy, will be performed under general anesthesia in the prone position with horizontal. The level of the spine indicated for surgical treatment will be identified with the aid of fluoroscopy. An incision is made about the dorsal disc level involved with dissection of the paravertebral muscles on the side of disc herniation. After laminectomy and resection of part of the yellow ligament, partial discectomy is done under direct vision.
Study NCT01367860 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Percutaneous Diskectomy SpineJet
Description: Percutaneous Diskectomy SpineJet be performed under local anesthesia, in which a needle is placed via percutaneous posterolateral extra-pedicular, below the neural foramen in the center of the disc, using the traditional approach for discography. The researcher will confirm the proper placement of the needle in front and side incidences on the fluoroscopy.
Study NCT03579030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo oral capsule
Description: Placebo capsule matched to an RTA 1701 capsule
Study NCT00368030 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet
Study NCT01937520 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: One half of subjects will receive a standardized acupuncture regiment
Study NCT01937520 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: no acupuncture
Description: placebo
Study NCT02185534 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Description: European clopidogrel tablets, 75 mg (test) versus Japanese clopidogrel tablets, 75 mg (reference); European clopidogrel tablets, 75 mg (test) versus US clopidogrel tablets, 75 mg (reference)
Study NCT03579030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RTA 1701 capsules
Description: Capsule containing RTA 1701, multiple dosages
Study NCT03954977 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PICC line ultrasound
Description: NICU patient's with PICC lines will be enrolled and blinded ultrasound operators will scan the neonate to find the PICC tip location. This will be compared to the location on the patient's chest x-ray. This process will be repeated each time the patient has a chest x-ray.
Study NCT01634945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SP/amodiaquine
Description: One dose of SP (500 mg sulfadoxine plus 25 mg pyrimethamine, or half of the dose if body weight =\< 10 kg) and three daily doses of Amodiaquine (1. Day: 200 mg, 2. Day: 200 mg and 3. Day: 100 mg, or half of the dose each day if body weight =\< 10 kg), every three months, i.e. 3 times during 9 consecutive months.
Study NCT01634945 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: FeFum fortified porridge
Description: 6 times per week supply of iron fortified porridge (25 g portion containing 5.8 mg of iron: 2 mg as NaFeEDTA + 3.8 mg as ferrous fumarate) for 9 months.
Study NCT01634945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SP/Amodiaquine + FeFum fortified porridge
Description: One dose of SP (500 mg sulfadoxine plus 25 mg pyrimethamine, or half of the dose if body weight =\< 10 kg) and three daily doses of Amodiaquine (1. Day: 200 mg, 2. Day: 200 mg and 3. Day: 100 mg, or half of the dose each day if body weight =\< 10 kg), every three months, i.e. 3 times during 9 consecutive months.~6 times per week supply of iron fortified porridge (25 g portion containing 5.8 mg of iron: 2 mg as NaFeEDTA + 3.8 mg as ferrous fumarate) for 9 months.
Study NCT01634945 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ferric pyrophosphate fortified porridge
Description: 6 days per week supply of iron fortified porridge (25 g portion containing 5.8 mg of iron: 2 mg as NaFeEDTA + 3.8 mg as ferric pyrophosphate) for 9 months.
Study NCT02185534 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clopidogrel
Description: European clopidogrel tablets, 75 mg (test) versus Japanese clopidogrel tablets, 75 mg (reference); European clopidogrel tablets, 75 mg (test) versus US clopidogrel tablets, 75 mg (reference)
Study NCT04236089 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: robotic hand
Description: mirror therapy with robotic hand
Study NCT01634945 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo of SP/Amodiaquine every 3 months for 9 months. No dietary intervention.
Study NCT02467855 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: No intervention was administered in this study.
Study NCT01270958 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avamys aqueous nasal spray 110mcg
Description: At the visit 1, subjects who fulfill the inclusion criteria are eligible to be included in the group to self-administer intranasal treatment of fluticasone furoate aqueous nasal spray 110 mcg once daily for 6 week. The subjects are instructed to administer two sprays from the device into each nostril once daily every morning. Administration of the dose will be performed by alternately spraying one spray to each nostril followed by a second spray to each nostril. Subjects will not be permitted to take any anti-allergy or rhinitis medication during the screening or treatment period.~Throughout the study, subjects will document their study drug administration/compliance, any medical conditions experienced, and any concomitant medications taken.
Study NCT01812070 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT
Study NCT01812070 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBT
Study NCT03915912 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Description: The study intervention consists of seven mindfulness sessions (six 1-hour telephone sessions and one 1-hour in-person session). The six weekly telephone-based mindfulness sessions will occur in a one-on-one format and will be followed by one in-person, one-on-one session, which will occur at the post-chemoradiation standard of care clinic visit.
Study NCT03470857 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Patients
Description: The FDG PET/CT imaging will be performed as part of typical medical procedures related to the diagnosis and monitoring of cancers at the Oncology Center in Bydgoszcz, Poland
Study NCT03595384 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Soccer-based adaptation to the DPP
Description: Participants will complete online education modules during an initial 12 week conditioning phase where they will participate in soccer drills and other fitness routines (two 1-hour sessions per week). At the 12 week mark participants will transition onto a soccer league team for the following 12 weeks where they will continue to complete online modules and meet with the soccer coach monthly.~During the soccer sessions and games participants will be fitted with a wearable soccer-specific device to measure how much they move and their heart rate. In addition, they will also be asked to wear a Garmin fitness tracker for the duration of the study to measure steps and moderate and vigorous activity.~The online education will be a version of the Diabetes Prevention Program and can be completed on a phone or computer with internet access.
Study NCT00860990 — intervention group
Intervention type: OTHER
Intervention: Completion of GI quality of life survey
Description: Subjects are asked to complete a survey related to bowel care and its effects on various variables related to quality of life.
Study NCT03729843 — intervention group
Intervention type: RADIATION
Intervention: CBCT and intraoral digital radiography
Description: Simulated periodontal bone defects will be measured by 2 techniques: group I detected and measured using CBCT and group II intraoral digital radiography and all the measurements will be compared with the gold standard real measurements on the dry jaws
Study NCT04668092 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional dry needling
Description: functional dry needling applied to hamstring for 1 minute and post interventional data collected
Study NCT06379438 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (indocyanine green+laser)
Description: Photodynamic therapy with indocyanine green
Study NCT01052519 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Goal directed fluid therapy
Description: Fluid will be administered to reach maximal stroke volume during the intraoperative period.
Study NCT03482128 — intervention group
Intervention type: DEVICE
Intervention: Coagulation management guided by SONOCLOT
Description: Application of blood products guided by SONOCLOT measurements
Study NCT03482128 — intervention group
Intervention type: DEVICE
Intervention: Standard coagulation management
Description: Application of blood products based on clinical experience of the anesthesiologist in charge
Study NCT00357422 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Operation
Description: No drug needed